FDA.reportPublic FDA data

HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)

Substance profile for UNII G4U024CQK6, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
G4U024CQK6
Preferred term
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
Registry number
9050-31-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1368892
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1368892mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1368892
FDA Substance Registration SystemG4U024CQK6precision.fda.gov/uniisearch/srs/unii/G4U024CQK6

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use IRENKA safely and effectively. See full prescribing information for IRENKA. Irenka™ (Duloxetine Delayed-release Capsules USP) for oral use. Initial U.S. Approval: 20041
Regular Strength Enteric Anti-inflammatory/Analgesic Aspirin1
These highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
These highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 198923
These highlights do not include all the information needed to use duloxetine delayed-release capsules safely and effectively. See full prescribing information for duloxetine delayed-release capsules. DULOXETINE delayed-release capsules for oral use. Initial U.S. Approval: 20041
These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP . DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20041
BIAXIN (CLARITHROMYCIN) TABLET, FILM COATED BIAXIN (CLARITHROMYCIN) TABLET, FILM COATED, EXTENDED RELEASE BIAXIN (CLARITHROMYCIN) GRANULE, FOR SUSPENSION [ABBVIE INC.]1531
ASPIRIN TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1002
CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [ACTAVIS PHARMA, INC.]31
DOXYCYCLINE HYCLATE DELAYED RELEASE (DOXYCYCLINE HYCLATE) TABLET, DELAYED RELEASE [HERITAGE PHARMACEUTICALS INC.]16
DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]15
DULOXETINE CAPSULE, DELAYED RELEASE [LUPIN PHARMACEUTICALS, INC.]13
DULOXETINE CAPSULE, DELAYED RELEASE PELLETS [DR. REDDY'S LABORATORIES LIMITED]9
DULOXETINE CAPSULE, DELAYED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]7
DULOXETINE CAPSULE, DELAYED RELEASE [BLUEPOINT LABORATORIES]6
DULOXETINE CAPSULE, DELAYED RELEASE [TRIGEN LABORATORIES, LLC]6
DULOXETINE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING]4
DULOXETINE CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]4
DULOXETINE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]4
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [REMEDYREPACK INC. ]4
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]4
LAMOTRIGINE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED]3
OMEPRAZOLE CAPSULE, DELAYED RELEASE [GLENMARK PHARMACEUTICALS INC., USA]3
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [REMEDYREPACK INC. ]2
RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [AVKARE, INC.]2
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [TORRENT PHARMACEUTICALS LIMITED]2
ASPIRIN TABLET [QUALITEST PHARMACEUTICAL, INC.]1
ASPIRIN TABLET, DELAYED RELEASE [TIME CAP LABORATORIES INC.]1
DIVALPROEX SODIUM TABLET, DELAYED RELEASE [DR. REDDY'S LABORATORIES LTD]1
DULOXETINE CAPSULE, DELAYED RELEASE [CADILA HEALTHCARE LIMITED]1
DULOXETINE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ]1
DULOXETINE CAPSULE, DELAYED RELEASE PELLETS [MEDSOURCE PHARMACEUTICALS]1
DULOXETINE CAPSULE, DELAYED RELEASE PELLETS [PREFERRED PHARMACEUTICALS, INC.]1
MINIPRIN (ASPIRIN) TABLET, COATED [TIME CAP LABORATORIES, INC]1
NEW CORRECT (BISACODYL) TABLET, DELAYED RELEASE [TIME-CAP LABS, INC]1
OMEPRAZOLE CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]1
OMEPRAZOLE CAPSULE, DELAYED RELEASE [PREFERRED PHARMACEUTICALS INC]1
OMEPRAZOLE CAPSULE, DELAYED RELEASE [PROFICIENT RX LP]1
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS]1
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS INC.]1
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS INC.]1
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [PROFICIENT RX LP]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII G4U024CQK6 page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311CAPSULEORAL63.92 mg
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311CAPSULE, DELAYED RELEASEORAL586 mg
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311CAPSULE, EXTENDED RELEASEORAL44 mg
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311GRANULE, FOR SUSPENSIONORAL1217 mg
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311TABLETORAL152 mg
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)G4U024CQK69050311TABLET, EXTENDED RELEASEORAL31 mg